BRVE
Braveheart Bio, Inc.
NASDAQ · Healthcare · Biotechnology · US
$21.19
−2.62%Income statement
No reported periods for this listing yet.
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry